ARID1A and neoplasm: High ARID1A expression was correlated with the risk of death (HR = 1.95, 95% CI = 1.09–3.47) and disease recurrence (HR=2.08, 95% CI = 1.23–3.51); ARID1A promotes tumor initiation via CYP450-mediated oxidative damage